Clinical Trials Browser

Triple Negative Breast Neoplasms × Tiragolumab × Breast × Clear all

NCT06342037 2024-09-19

TONIC-3

Phase 2 Recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT04584112 2023-03-15

A Study of the Safety, Efficacy, and Pharmacokinetics of Tiragolumab in Combination With Atezolizumab and Chemotherapy in Participants With Triple-Negative Breast Cancer

Phase 1 Completed

Triple Negative Breast Neoplasms